Pfizer Inc. recalls 8.4 % Sodium Bicarbonate Injection
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Presence of Particulate Matter; identified as glass
- Products
-
- 8.4 % Sodium Bicarbonate Injection
- Company
- Pfizer Inc.
- Where it was sold
-
Nationwide in the USA and Puerto Rico.
Nationwide
- Units affected
- 21200 Cartons
- About this recall
- 8.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 50 mL Syringe per Carton, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6637-24 (carton), 0409-6637-14 (case).